replicatorblog

8 ms·

31.
by replicatorblog 7y ago
Veeva raised $4M in VC to build CRM for life sciences and currently has a $21B market cap. It's one of the 15 or so best exits of the last decade. I agree that comparing biology today to transistors in the 1950s might seem hubristic. B
32.
“Why Now?” Is a Weak Question(medium.com)
1 points by replicatorblog 7y ago|0 comments
33.
“Brain-Picking” is for Zombies – Here are better ways to ask for someone’s time(medium.com)
1 points by replicatorblog 7y ago|0 comments
34.
Is Your Pitch Deck a Book Report or a Treasure Map?(medium.com)
1 points by replicatorblog 7y ago|0 comments
35.
Taking less capital and a lower valuation can make you rich(medium.com)
2 points by replicatorblog 7y ago|0 comments
36.
by replicatorblog 7y ago
This is an often stated criticism of modern Lego designs, but I wonder if anyone has tried to test this empirically? E.g. if you gave a group of kids a "classic" set and another a themed set, with no further instructions, would th
37.
by replicatorblog 7y ago
This is accurate, but the sense I get is that there's a deliberate effort to move from licensed IP to Lego-created brands. E.g. there are vastly more "Friends" kits, the Lego house brand targeted at girls, than Disney princes
38.
Confidence: The Currency of Acceleration(techcrunch.com)
1 points by replicatorblog 7y ago|0 comments
39.
Startup Success Outside Silicon Valley: Data from over 200 Exits in 17 Cities(medium.com)
5 points by replicatorblog 7y ago|0 comments
40.
by replicatorblog 7y ago
This sentiment drifts dangerously close to a conspiracy theory. The existence of the vaccine industry demonstrates there is a market for a cure. As do immunotherapies. Where cures are possible, they are commercialized.
41.
A Checklist for My Friend Fundraising for a Seed Round(medium.com)
1 points by replicatorblog 7y ago|0 comments
42.
by replicatorblog 7y ago
United Health Care, one of the largest private insurers in the US covers more lives than the Canadian Government and has every incentive to negotiate low prices. This simple answer is satisfying to many who otherwise prefer single-payer pla
43.
Why Do VCS Want to See Your Financial Model?(medium.com)
2 points by replicatorblog 7y ago|0 comments
44.
by replicatorblog 7y ago
Sure, 1) The founder makes the case that if they reach a critical mass of "X users," or "Y Transaction volume," or another relevant metric there will be a windfall to be shared. 2) The investor evaluates the viability of
45.
by replicatorblog 7y ago
I think a lot of Patreon's controversial decisions, e.g. raising fees, have come largely because they gave VCs control. I have no inside knowledge, but Patreon seems to be straining to meet the needs of its creators while also reachi
46.
What to Do When a Co-Founder Can’t Scale(medium.com)
1 points by replicatorblog 7y ago|0 comments
47.
Dear Hollywood: Here are female founders to showcase instead of Elizabeth Holmes(techcrunch.com)
2 points by replicatorblog 7y ago|0 comments
48.
A Ridiculously Detailed Fundraising Guide(medium.com)
3 points by replicatorblog 7y ago|0 comments
49.
A Ridiculously Detailed Fundraising Guide(medium.com)
8 points by replicatorblog 7y ago|0 comments
50.
Twenty Lines to Write Before Starting Your Pitch Deck(medium.com)
1 points by replicatorblog 8y ago|0 comments
51.
The six-step playbook to pursuing M&A opportunities as a founder(producthunt.com)
1 points by replicatorblog 8y ago|0 comments
52.
by replicatorblog 8y ago
With Amazon, I have the ability to list my product, and buy ads pointing people directly to it. With physical retailers, I have to hope I can convince the retailer to stock it, often have to pay up front for shelf space, and then have to co
53.
by replicatorblog 8y ago
That seems like the weakest part of the argument — Walmart, Kroger, Walgreens, Costco, and every other major retailer has a similar program. All use sales data to determine what sells best and copy it. I did this for a decade, designing sto
54.
by replicatorblog 8y ago
This is an important point. There's nothing to stop Harvard or Stanford from commercializing their research directly. They have massive endowments of financial and human capital. The flip critique of the drug industry is to suggest the
55.
VC Doesn’t Make Recruiting (Much) Easier(hackernoon.com)
1 points by replicatorblog 8y ago|0 comments
56.
VC Doesn't Make Recruiting (Much) Easier(medium.com)
1 points by replicatorblog 8y ago|0 comments
57.
Pitch Rescue: Investor Presentation Pitfalls to Avoid(medium.com)
3 points by replicatorblog 8y ago|0 comments
58.
Your pitch deck isn’t an application for financial aid(hackernoon.com)
2 points by replicatorblog 8y ago|0 comments
59.
Four words that could kill your startup(hackernoon.com)
2 points by replicatorblog 8y ago|0 comments
60.
Four words that could kill your startup – and seven sentences that can save it(medium.com)
2 points by replicatorblog 8y ago|0 comments

More ›